Literature DB >> 25792091

Sulfonylureas--a novel treatment to reduce tissue damage after acute spinal cord injury?

Hagen Kunte1, H Francis Farhadi2, Kevin N Sheth3, J Marc Simard4, Golo Kronenberg5.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25792091      PMCID： PMC4701047          DOI： 10.1016/S1474-4422(15)70013-X

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  5 in total

Review 1.  Restoring function after spinal cord injury: towards clinical translation of experimental strategies.

Authors:  Leanne M Ramer; Matt S Ramer; Elizabeth J Bradbury
Journal:  Lancet Neurol       Date:  2014-11-10       Impact factor: 44.182

2.  A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury.

Authors:  Robert G Grossman; Michael G Fehlings; Ralph F Frankowski; Keith D Burau; Diana S L Chow; Charles Tator; Angela Teng; Elizabeth G Toups; James S Harrop; Bizhan Aarabi; Christopher I Shaffrey; Michele M Johnson; Susan J Harkema; Maxwell Boakye; James D Guest; Jefferson R Wilson
Journal:  J Neurotrauma       Date:  2013-10-11       Impact factor: 5.269

3.  Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury.

Authors:  J Marc Simard; Orest Tsymbalyuk; Kaspar Keledjian; Alexander Ivanov; Svetlana Ivanova; Volodymyr Gerzanich
Journal:  Exp Neurol       Date:  2011-12-08       Impact factor: 5.330

4.  Sulfonylurea receptor 1 expression in human cerebral infarcts.

Authors:  Rupal I Mehta; Svetlana Ivanova; Cigdem Tosun; Rudy J Castellani; Volodymyr Gerzanich; J Marc Simard
Journal:  J Neuropathol Exp Neurol       Date:  2013-09       Impact factor: 3.685

5.  Glibenclamide for the treatment of acute CNS injury.

Authors:  David B Kurland; Cigdem Tosun; Adam Pampori; Jason K Karimy; Nicholas M Caffes; Volodymyr Gerzanich; J Marc Simard
Journal:  Pharmaceuticals (Basel)       Date:  2013-10-11
  5 in total
  2 in total

1.  Human menstrual blood-derived stem cells promote functional recovery in a rat spinal cord hemisection model.

Authors:  Qinfeng Wu; Qinghua Wang; Zhangjie Li; Xiangzhe Li; Jing Zang; Zhangwei Wang; Chen Xu; Yujia Gong; Jiaqi Cheng; Haoming Li; Guangyu Shen; Chuanming Dong
Journal:  Cell Death Dis       Date:  2018-08-29       Impact factor: 8.469

2.  Factors related to improved American Spinal Injury Association grade of acute traumatic spinal cord injury.

Authors:  Ci Tian; Yang Lv; Shu Li; Dai-Dai Wang; Yi Bai; Fang Zhou; Qing-Bian Ma
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.